{{expand|time=2017-12-24T17:31:28+00:00}}
{{Drugbox
| verifiedrevid = 470634701
| IUPAC_name = 17α-hydroxy-yohimban-16α-<br />carboxylic acid methyl ester
| image = Yohimbine structure.svg
| width = 200
| image2 = Yohimbine3Dan.gif
| width2 = 250

<!--Clinical data-->
| tradename = Actibine, Erex, Testomar, Yocon, Yohimar, Yohimbe
| pregnancy_category =  
| legal_AU = S4
| routes_of_administration = 口服

<!--Pharmacokinetic data-->
| bioavailability = 0
| metabolism =  
| excretion = Urine (as metabolites)
| elimination_half-life = 0.25-2.5 hours<ref>{{cite journal|title=Yohimbine pharmacokinetics and interaction with the sympathetic nervous system in normal volunteers|url=https://archive.org/details/sim_european-journal-of-clinical-pharmacology_1992-12_43_6/page/651|journal=European Journal of Clinical Pharmacology|date=1992|volume=43|issue=6|pages=651-656|pmid=1493849|doi=10.1007/BF02284967|author=Hedner, T; Edgar, B; Edvinsson, L; Hedner, J; Persson, B; Pettersson, A}}</ref>

<!--Identifiers-->
| CASNo_Ref = {{cascite|correct|CAS}}
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 146-48-5
| ATC_prefix = G04
| ATC_suffix = BE04
| ATC_supplemental = {{ATCvet|V03|AB93}}
| PubChem = 8969
| IUPHAR_ligand = 102
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01392
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 8622
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 2Y49VWD90Q
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 10093
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 15245

<!--Chemical data-->
| C=21 | H=26 | N=2 | O=3
| molecular_weight = 354.44 g/mol (base)<br />390.90 g/mol (hydrochloride)
| smiles = O=C(OC)[C@@H]5[C@H]4C[C@H]3c2nc1ccccc1c2CCN3C[C@@H]4CC[C@@H]5O
| InChI = 1S/C21H26N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,17-19,22,24H,6-11H2,1H3/t12-,15-,17-,18-,19+/m0/s1
| InChIKey = BLGXFZZNTVWLAY-SCYLSFHTSA-N
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C21H26N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,17-19,22,24H,6-11H2,1H3/t12-,15-,17-,18-,19+/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = BLGXFZZNTVWLAY-SCYLSFHTSA-N
}}

{{medical}}

'''育亨宾'''（{{lang-en|Yohimbine}}）是一种温和的[[单胺氧化酶抑制剂|单胺氧化酶抑制剂]]，并具有[[春药|壮阳]]与[[兴奋剂|兴奋剂]]功效。它作为[[疗法|治疗]][[性功能障碍|性功能障碍]]的[[医学|医用]][[處方藥|處方藥]]销售。育亨宾也是携带α<sub>2A</sub>肾上腺素受体基因多态性的人类与动物模型的[[2型糖尿病|2型糖尿病]]治疗的探索药物<ref>{{cite journal |last1=Rosengren |first1=A. H. |last2=Jokubka |first2=R. |last3=Tojjar |first3=D. |last4=Granhall |first4=C. |last5=Hansson |first5=O. |last6=Li |first6=D.-Q. |last7=Nagaraj |first7=V. |last8=Reinbothe |first8=T. M. |last9=Tuncel |first9=J. | displayauthors = 8|title=Overexpression of Alpha2A-Adrenergic Receptors Contributes to Type 2 Diabetes |journal=Science |volume=327 |issue=5962 |pages=217–20 |year=2009 |pmid=19965390 |doi=10.1126/science.1176827}}</ref>。

育亨宾的商品名有：Erex、Testomar、Yocon、Yohimar、Yohimbe等。

==合成==
[[File:Yohimbine_synthesis.png|thumb]]

== 参考文献 ==
{{Reflist|2}}

{{色胺}}
{{Aphrodisiacs}}
{{Hallucinogens}}

[[Category:甲型受體阻斷劑|Category:甲型受體阻斷劑]]
[[Category:宗教致幻剂|Category:宗教致幻剂]]
[[Category:单胺氧化酶抑制剂|Category:单胺氧化酶抑制剂]]
[[Category:致焦虑剂|Category:致焦虑剂]]
[[Category:吲哚生物碱|Category:吲哚生物碱]]
[[Category:血管扩张剂|Category:血管扩张剂]]
[[Category:血管收縮藥|Category:血管收縮藥]]